Type
- ARTG (494)
- Cancellation by sponsor (465)
- Australian Public Assessment Report (AusPAR) (63)
- Prescription medicine registration (41)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (2)
Date
- 2024 (62)
- 2023 (73)
- 2022 (61)
- 2021 (126)
- 2020 (107)
- 2019 (98)
- 2018 (98)
- 2017 (74)
- 2016 (12)
- 2015 (22)
- 2014 (23)
- 2013 (9)
- 2012 (9)
- 2011 (14)
- 2010 (29)
- 2009 (13)
- 2008 (6)
- 2007 (12)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (9)
- 2002 (13)
- 2001 (8)
- 2000 (22)
- 1999 (12)
- 1998 (12)
- 1997 (18)
- 1996 (8)
- 1995 (3)
- 1994 (33)
- 1993 (19)
- 1992 (8)
- 1991 (88)
Results for
"[search-keyword]"
Sponsor content
1121 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection single dose vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 5/5 micrograms/0.3 mL suspension for injection single dose vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 5/5 micrograms/0.3 mL suspension for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 5/5 micrograms/0.2 mL concentrated suspension for injection vial.
-
Prescription medicine registrationActive ingredients: abrocitinib.
-
Prescription medicine registrationActive ingredients: recombinant respiratory syncytial virus pre-fusion F protein, water for injections.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pfizer Australia Pty Ltd - Skin-cleaning wipe, sterile.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pfizer Australia Pty Ltd - Skin-cleaning wipe, sterile.
-
Australian Public Assessment Report (AusPAR)Nurtec ODT (rimegepant) has been approved for the treatment of acute migraine and the prophylactic treatment of episodic migraine in adults
-
Mar-2024Prescription medicine evaluationActive ingredient: marstacimab.